Medical Device News Magazine

Nikon Introduces All New Spatial Array Confocal (NSPARC) Detector for AX

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Today, Nikon Instruments Inc. announced the Nikon Spatial Array Confocal (NSPARC) detector for AX systems. The newly developed confocal detector system utilizes an ultra-low noise detector array for point-scanning confocal data collection, improving signal-to-noise ratio and thus allowing imaging at lower excitation power.

This enables high-resolution imaging of live tissue with minimal phototoxicity. Scheduled for release at the beginning of February 2023, this product will be used in combination with AX or AX R confocal microscopes (released in 2021)*1.

*1. Compatible microscopes: ECLIPSE Ti2-E inverted research microscope, Eclipse FN1 physiology microscope, and ECLIPSE Ni-E motorized upright research microscope

Release Overview

Product

NSPARC super-resolution unit

Release Date

Beginning of February 2023

Development Background

Drug development, neuroscience, immunology, and cell biology research fields have experienced an increased need for greater capabilities in high quality observation of live cells, tissues, organs-on-a-chip*2, and other applications. To address these needs, Nikon designs and develops microscopes that push the limits of conventional optical technologies and contributes to numerous studies where high-resolution imaging is required.

Recently, Nikon released the AX and AX R confocal microscope systems, which can acquire clear, highly resolved images over a large field of view. Now, Nikon has developed the NSPARC detector, which further enhances AX and AX R’s capabilities for fast and low phototoxicity imaging. Specifically, NSPARC represents an all-new level of low noise detection, producing very high signal-to-noise ratio images with single photon sensitivity.  NSPARC provides optical resolving power beyond traditional limits, which combined with point-scanning, allows it to be used for high resolution applications beyond those of other super resolution techniques, such as structured illumination microscopy.

*2. Organ-derived cells cultivated in a minute flow path on a chip simulating an in vivo organ, which can efficiently evaluate the effectiveness and safety of a drug candidate compound with a higher degree of accuracy than conventional in vitro models.

Main Features

1.  A new level of detection that enables high-resolution, stable live-cell assays

By combining NSPARC’s remarkable ultra-low noise detector and an AX R equipped with a resonant scanner capable of high-speed imaging, high-resolution sample information can be acquired even during high-speed scanning. High-resolution and stable live-cell assays with less photobleaching and less phototoxicity are made possible by reducing the laser irradiation time and reducing damage to cells, while taking advantage of the high sensitivity NSPARC detector.

2.  High contrast 3D imaging

NSPARC’s spatial array detector improves sensitivity by a factor of 1.3*5 to additional spatial information for each scanning point, which can then be used for image processing. This makes it possible to acquire higher-contrast 3D images than traditional point scanning confocal, even in deep areas.

*5. Compared to AX and AX R confocal microscopes

3.  Deeper imaging than existing structured illumination products

NSPARC makes it possible to acquire data in larger samples than the existing N-SIM S super-resolution microscope supports. This enables high-resolution and high-precision morphological analysis of thick samples such as cranial nerves, organoids, and organs-on-a-chip.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”